In the mRNA vaccine maker’s 2024 Shareholder Letter, CEO Stéphane Bancel reflected upon the company’s second year ...
The €60 million ($63 million) Shanbally, Cork expansion aims to increase production capacity. The facility will manufacture bulk drug substances and drug products and perform fill-finish services. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback